Sign Up to like & get
recommendations!
1
Published in 2017 at "Circulation"
DOI: 10.1161/circulationaha.117.029190
Abstract: Background -Reduction in cardiovascular death and hospitalization for heart failure (HHF) was recently reported with the sodium-glucose co-transporter-2 inhibitor (SGLT-2i) empagliflozin in type 2 diabetes patients with atherosclerotic cardiovascular disease. We compared HHF and death…
read more here.
Keywords:
death;
hhf death;
initiated sglt;
heart failure ... See more keywords